September 9, 2023: Negotiations for this text were completed in May and the text was released on September 8. The text may be signed in November 2023, after which it will be tabled in Parliament and reviewed by the Joint Standing Committee on Treaties. It could come into force in the first quarter of 2024.
7 September, 2023: On August 17, the South African NGO Health Justice Initiative won a huge victory when the Pretoria High Court ruled that South Africa had to make its COVID procurement contracts public.
September 6, 2023 AFTINET Media release
Australia's Southeast Asia Economic Strategy to 2040 announced today will “review the scope of existing Free Trade Agreements to determine priorities for agreement upgrade negotiations.”
The Comprehensive and Progressive Agreement for Trans-Pacific Partnership Agreement (CPTPP), a free trade agreement between 11 countries; Australia, Brunei Darussalam, Canada, Chile, Japan, Malaysia, Mexico, Peru, New Zealand, Singapore and Vietnam, has now been in force for 5 years. This milestone means the CPTPP has to undergo a 5-year post-implementation review, which considers the impacts of the agreement since it has come into force.
30 August, 2023: This two-page explainer explores the links between Australian policy and bilateral critical minerals agreements, both of which aim to aim to diversify supply chains and reduce dependence on China, and Free Trade Agreements.
28 August, 2023: Negotiations to improve the international response for future pandemics are underway through talks for a new World Health Organisation Global Pandemic Agreement and amendments to the existing International Health Regulations.
22 August, 2023: The High Court in Pretoria, South Africa has ruled that Covid vaccine procurement contracts and related documents had to be made public. Judge Anthony Millar said “it is, in my view, self-evident that there is public interest in the disclosure of the records.”
4 August, 2023: India is currently negotiating Trade Agreements (FTAs) with the UK and EU, among other countries, which include demands for stricter intellectual property rules, threatening India’s production of generic medicines and role as “pharmacy of the world.”